GE to target Brazil with new molecular breast imaging system
This article was originally published in Clinica
GE Healthcare is eyeing Brazil as the first market for its newly launched Discovery NM750b molecular breast imaging system, intended to help screen high-risk women for breast cancer. The company unveiled the device for the first time yesterday, at the annual meeting of the European Association of Nuclear Medicine, currently being held in Birmingham, UK, from 15-19 October.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.